05.03.2007 23:33:00
|
HealthTronics Signs Exclusive Agreement for Surgical Laser Technology
HealthTronics, Inc. (NASDAQ: HTRN), a leading provider of urology
services and products, today announces the completion of a long term
supply and development agreement with Lisa Laser OHG and Lisa Laser USA,
a leading developer and manufacturer of surgical lasers for use in
treating benign prostatic hyperplasia (BPH) and performing
intracorporeal lithotripsy. The agreement includes exclusive rights in
the United States for the RevoLix surgical laser and holmium laser
technology. In addition, the agreement includes a right of first refusal
for all future laser technology with urology applications.
The RevoLix laser’s ability to both vaporize
and vaporesect prostate tissue positions it as the leading technology
for treatment of BPH. HealthTronics has created a clinical education
organization to promote the clinical outcomes of the RevoLix and to
actively market the innovative multi-use XFiberTM
and SureViewTM surgical technique.
Christopher Schneider, President of Medical Products stated: "For
the last twelve months we have had a successful relationship with Lisa
Laser focused on the RevoLix surgical laser for BPH. The clinical
benefits to the patients and economic benefits to our physician partners
have been significant and have allowed us to make an impact on the
market for photoselective vaporization (PVP) of the prostate. We now
have over 270 physician users and have performed 2,200 cases in the past
ten months. Our recent success is only the start of a much larger
initiative we have underway to bring this exclusive forward firing,
continuous wave laser technology to the broader urology market. We have
built a distribution and clinical education organization from industry
veterans in order to compete in the rapidly growing PVP market for BPH.
With the PVP market growing at nearly 20% annually, we believe the
current portfolio of products, combined with the future technology being
developed, will position HealthTronics extremely well in the rapidly
expanding market for urological laser technology. Finally, we are quite
pleased with Lisa Laser’s reputation for
quality, innovativeness and its future R&D pipeline. This relationship
will be a key contributor to our growth initiative.”
Lisa Laser OHG is based in Katlenburg, Germany.
HealthTronics is a premier urology company providing an exclusive
suite of healthcare services and technology including urologist
partnership opportunities, surgical and capital imaging equipment,
maintenance services offerings, and clinical and anatomical pathology
services.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu HealthTronics Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |